Yamane Ayaka, Higuchi Hitoshi, Tomoyasu Yumiko, Ishii-Maruhama Minako, Maeda Shigeru, Miyawaki Takuya
Clinical Staff, Department of Dental Anesthesiology, Okayama University Hospital, Okayama, Japan.
Senior Assistant Professor, Department of Dental Anesthesiology, Okayama University Hospital, Okayama, Japan.
J Oral Maxillofac Surg. 2015 Apr;73(4):616-21. doi: 10.1016/j.joms.2014.09.029. Epub 2014 Oct 17.
Recently, attention has been paid to dexmedetomidine, a selective α-2 adrenoceptor agonist, as a possible additive for local anesthesia. However, the effect of locally injected dexmedetomidine on the anesthetic action in humans has not fully been clarified. Thus, the purpose of the present study was to evaluate the effect of dexmedetomidine injected into the oral mucosa in combination with lidocaine on local anesthetic potency in humans.
Twenty healthy volunteers were included in the present crossover double-blinded study. Lidocaine solution or lidocaine plus dexmedetomidine solution was submucosally injected into the alveolar mucosa in a crossover and double-blinded manner. The local anesthetic effect of the solutions was evaluated by measuring the current perception threshold (CPT) in the oral mucosa for 120 minutes after injection. Furthermore, the sedation level, blood pressure, and heart rate of the volunteers were evaluated. For statistical analysis, the Wilcoxon signed rank test and 2-way repeated measures analysis of variation were used.
The CPT was increased with the 2 solutions and peaked 10 minutes after injection. CPT values 10 and 20 minutes after injection of lidocaine plus dexmedetomidine solution were considerably higher than those with lidocaine solution. The duration of an important increase in the CPT after injection with lidocaine plus dexmedetomidine solution was longer than that with lidocaine. Furthermore, the area under the time curve of CPT was considerably higher with lidocaine plus dexmedetomidine solution than with lidocaine solution. No volunteer showed a change in sedation level, blood pressure, or heart rate after injection with either test solution throughout the experiment.
The present study showed that a combination of dexmedetomidine plus lidocaine considerably enhances the local anesthetic potency of lidocaine without any major influences on the cardiovascular system when locally injected into the oral mucosa.
最近,右美托咪定这种选择性α-2肾上腺素能受体激动剂作为局部麻醉的一种可能添加剂受到了关注。然而,局部注射右美托咪定对人体麻醉作用的影响尚未完全阐明。因此,本研究的目的是评估右美托咪定与利多卡因联合注射到口腔黏膜中对人体局部麻醉效能的影响。
本交叉双盲研究纳入了20名健康志愿者。以交叉双盲方式将利多卡因溶液或利多卡因加右美托咪定溶液黏膜下注射到牙槽黏膜中。通过测量注射后120分钟口腔黏膜中的电流感觉阈值(CPT)来评估溶液的局部麻醉效果。此外,还对志愿者的镇静水平、血压和心率进行了评估。统计分析采用Wilcoxon符号秩检验和双向重复测量方差分析。
两种溶液注射后CPT均升高,并在注射后10分钟达到峰值。注射利多卡因加右美托咪定溶液后10分钟和20分钟的CPT值明显高于利多卡因溶液。注射利多卡因加右美托咪定溶液后CPT显著升高的持续时间比利多卡因长。此外,利多卡因加右美托咪定溶液的CPT时间曲线下面积明显高于利多卡因溶液。在整个实验过程中,没有志愿者在注射任何一种测试溶液后出现镇静水平、血压或心率的变化。
本研究表明,右美托咪定加利多卡因联合使用可显著增强利多卡因的局部麻醉效能,且局部注射到口腔黏膜时对心血管系统无任何重大影响。